A publication involving elamipretide appeared on September 17, 2026. The paper, titled "Mitochondrial Quality Control in Inherited Mitochondrial Cardiomyopathy: Convergent Pathobiology and a Testable Therapeutic Framework," was published in the International Journal of Molecular Sciences.
The publication is listed under PubMed ID 42794697. It addresses mitochondrial quality control mechanisms in the context of inherited mitochondrial cardiomyopathy and proposes a therapeutic framework described as testable.
No results, efficacy data, or safety findings from this publication are detailed here. This brief reports only the existence and bibliographic details of the publication as provided.
Elamipretide is currently classified as an approved compound. Readers interested in the broader context of this publication, including its full content and any data on mitochondrial quality control frameworks, should consult the source directly.
For general background on elamipretide, including its approved uses and development history, readers can consult the compound overview.